Suchergebnisse - "Liu, Shuying"

PubPharm (32)

1

Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment

enthalten in: Breast cancer research : BCR | 2023

von Liu, S. | Xie, S. | Liu, W. | +12

UpdateOf: Res Sq. 2023 Feb 14;:. - PMID 36824840

2

Autotaxin exacerbates tumor progression by enhancing MEK1 and overriding the function of miR-489-3p

enthalten in: Cancer letters | 2018

von Kuppa, S. | Jia, W. | Liu, S. | +6

3

Using DNA Immunization to Elicit Monoclonal Antibodies in Mice, Rabbits, and Humans

enthalten in: Human gene therapy | 2018

von Liu, S. | Wang, S. | Lu, S.

4

The wide utility of rabbits as models of human diseases

enthalten in: Experimental & molecular medicine | 2018

von Esteves, P. | Abrantes, J. | Baldauf, H. | +34

ErratumIn: Exp Mol Med. 2019 Jul 4;51(7):1. - PMID 31270317

5

Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines

enthalten in: Human vaccines & immunotherapeutics | 2017

von Wang, S. | Chou, T. | Hackett, A. | +11

6

The dynamics of immunoglobulin V-gene usage and clonotype expansion in mice after prime and boost immunizations as analyzed by NGS

enthalten in: Human vaccines & immunotherapeutics | 2017

von Farfán-Arribas, D. | Liu, S. | Wang, S. | +1

7

DNA immunization as a technology platform for monoclonal antibody induction

enthalten in: Emerging microbes & infections | 2016

von Liu, S. | Wang, S. | Lu, S.

8

Prevalence of Kaposi's sarcoma associated herpesvirus among men attending sexually transmitted infections clinics in Anhui, China

enthalten in: Journal of medical virology | 2016

von Wang, J. | Liu, S. | Cao, Y. | +5

9

Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomes

enthalten in: Clinical breast cancer | 2015

von Parinyanitikul, N. | Lei, X. | Chavez-MacGregor, M. | +9

10

SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer

enthalten in: Journal of the National Cancer Institute | 2015

von Gonzalez-Angulo, A. | Krop, I. | Akcakanat, A. | +15